Notice of Intent to Sole Source – QIAGEN
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) Clinical Center (CC) Department of Laboratory Medicine (DLM) intends to award a fixed-price purchase order to QIAGEN, LLC for the continued provision of reagents, supplies, and annual preventative maintenance services for clinical testing instrumentation. This is a Notice of Intent to Sole Source, not a request for quotation. Responses from interested parties are due March 25, 2026, at 11 am EST.
Scope of Work
This acquisition covers:
- Reagents and supplies from QIAGEN for clinical testing at NIH CC DLM.
- Annual preventative maintenance services for instrumentation. The place of performance is Bethesda, MD 20892 USA.
Contract & Timeline
- Type: Fixed-Price Purchase Order (Sole Source)
- Set-Aside: None (Sole Source Justification)
- Response Due: March 25, 2026, 11 am EST
- Published: March 18, 2026
Sole Source Justification
The NIH intends to award this contract to QIAGEN, LLC on a sole source basis because QIAGEN is identified as the sole manufacturer and authorized service provider for the instrumentation. As the sole developer and manufacturer, QIAGEN is the only vendor from which these specific reagents and supplies can be purchased. This acquisition is being conducted under FAR Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), which allows for solicitation from one source when circumstances deem only one source reasonably available.
Additional Notes
This is a notice of intent, and a solicitation document will not be issued. Quotations will not be requested. Interested parties may identify their interest and capabilities in response to this posting. The government's determination not to compete this requirement is solely at its discretion. Comments should be submitted to Kristin Nagashima via email.